| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 305.89 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Erythematosus Systemic Lupus is a chronic inflammatory disease that affects about half a million Europeans, more frequent in the southern countries and fertile women. The therapy adherence in this disease is not well known, particularly in Portugal.
Objectives: To characterize the medication therapy of Lupus, estimate the prevalence of therapy adherence and associated factors in Portugal.
Methods: This exploratory, cross-sectional and correlational study was based on a questionnaire, with MAT scale (measure of adherence to therapy) validated for the Portuguese population (Delgado & Lima, 2001), applied to 276 members of Patients with Lupus Association, in Portugal. It was used descriptive statistics and Chi-Square test, with a significance level of 5%.
Results: The sample consisted mostly of females (96.0%), with an average age of 41 (± 11.46) years old. Antimalarials, antiinflammatory and immunosuppressive drugs are the pharmacotherapeutic groups more used. The prevalence of therapy adherence was 80.2%. Factors associated with Lupus therapy nonadherence are side effects, do not feel improvement, not acceptance, disease in remission and do not feel the need to treat (p<0.05).
Conclusions: This study shows a considerable prevalence of Lupus therapy adherence, being several factors associated with nonadherence. It is important the intervention of health professionals to improve therapy adherence for disease control.
Description
Keywords
Erythematosus systemic lupus Therapy adherence
Citation
Pinto, Isabel C.; Nascimento, Luís ; Faria, Ângela; Lopes, Márcia; Afonso, Sílvia (2016). Erythematosus systemic lupus in Portugal: adherence and approach to medication therapy. In 3rd World Congress of Health Research. Atención Primaria. ISSN 0212-6567. 48 (Esp Cong 1), p. 31-31
Publisher
Elsevier